Rickettsia rickettsii Infection Protects Human Microvascular Endothelial Cells against Staurosporine-Induced Apoptosis by a cIAP2-Independent Mechanism

Bechelli, Jeremy R.; Rydkina, Elena; Colonne, Punsiri M.; Sahni, Sanjeev K.
May 2009
Journal of Infectious Diseases;5/1/2009, Vol. 199 Issue 9, p1389
Academic Journal
Background. Manipulation of host cell death is an important determinant of the outcome of an infection. Here, we investigate whether Rickettsia rickettsii-infected host endothelial cells resist the effects of staurosporine, a potent inducer of apoptosis, and we explore the mechanisms underlying the anti-apoptotic effect of infection. Methods. Human microvascular endothelial cells infected with R. rickettsii for 24 or 48 h were challenged with staurosporine. The extent of apoptosis was evaluated with flow cytometry. mRNA and protein expression levels were determined by use of microarray or polymerase chain reaction and immunoblotting, respectively. Results. Staurosporine-induced apoptosis in endothelial cells infected for 24 and 48 h was significantly reduced, compared with simultaneously treated uninfected cells. A microarray of human genes involved in apoptosis and polymerase chain reaction analyses revealed increased steady-state mRNA expression of cIAP2 (a member of the inhibitor-of-apoptosis family of proteins) at 24 h after infection. The levels of cIAP2 protein (±SD) in infected cells were 3.5 ± 1.7-fold and 2.3 ± 1.2-fold higher than that in uninfected control cells at 24 and 48 h after infection. Nucleofection of human-specific cIAP2-targeted siRNA resulted in inhibition of protein expression by ⩾50% but had no effect on infection-induced protection against apoptosis. Conclusions. R. rickettsii-induced expression of cIAP2 in host endothelial cells is likely not a major contributor to protection against staurosporine-induced cell death.


Related Articles

  • Increased local vascular endothelial growth factor expression associated with antitumor activity of proteasome inhibitor. Stoklosa, T.; Golab, J.; Wójcik, C.; Wlodarski, P.; Jalili, A.; Januszko, P.; Giermasz, A.; Wilczyński, G. M.; Pleban, E.; Marczak, M.; Wilk, S.; Jakóbisiak, M. // Apoptosis;Mar2004, Vol. 9 Issue 2, p193 

    Inhibition of the proteasome, a multicatalytic proteinase complex, is an attractive approach to cancer therapy. Here we report that a selective inhibitor of the chymotrypsin-like activity of the proteasome, PSI (N-benzyloxycarbonyl-Ile-Glu(O-t-butyl)-Ala-leucinal) may inhibit growth of solid...

  • EFFECT OF VEGF ON NO-PRODUCTION BY ENDOTHELIAL CELLS. Bilyuk, A.; Nikolaenko, T.; Petruk, N.; Saraieva, I.; Dzhus, O.; Nikulina, V.; Andruschenko, O.; Garmanchuk, L. // Bulletin of Taras Shevchenko National University of Kyiv / Vestn;2013, Vol. 64 Issue 2, p43 

    It was established that VEGF ma anti-VEGF have an opposite effect on endothelium cells. VEGF stimulates production of NO and inhibits apoptosis, and anti-VEGD slightly decrease NO production rate and induce apoptosis.

  • Dihydroartemisinin downregulates vascular endothelial growth factor expression and induces apoptosis in chronic myeloid leukemia K562 cells. Jun Lee; Hui-Jun Zhou; Xiu-Hua Wu // Cancer Chemotherapy & Pharmacology;Feb2006, Vol. 57 Issue 2, p213 

    Dihydroartemisinin (DHA), a more water-soluble active metabolite of artemisinin derivatives, is safe and the most effective antimalarial analog of artemisinin. In the present investigation, we assessed the effect of DHA on vascular endothelial growth factor (VEGF) expression and apoptosis in...

  • Hyperoxia causes angiopoietin 2–mediated acute lung injury and necrotic cell death. Bhandari, Vineet; Choo-Wing, Rayman; Lee, Chun G.; Zhu, Zhou; Nedrelow, Jonathan H.; Chupp, Geoffrey L.; Zhang, Xucher; Matthay, Michael A.; Ware, Lorraine B.; Homer, Robert J.; Lee, Patty J.; Geick, Anke; de Fougerolles, Antonin R.; Elias, Jack A. // Nature Medicine;Nov2006, Vol. 12 Issue 11, p1286 

    The angiogenic growth factor angiopoietin 2 (Ang2) destabilizes blood vessels, enhances vascular leak and induces vascular regression and endothelial cell apoptosis. We considered that Ang2 might be important in hyperoxic acute lung injury (ALI). Here we have characterized the responses in lungs...

  • EMAP-II-dependent lymphocyte killing is associated with hypoxia in colorectal cancer. Youssef, M. M. S.; Symonds, P.; Ellis, I. O.; Murray, J. C. // British Journal of Cancer;9/18/2006, Vol. 95 Issue 6, p735 

    Endothelial-monocyte-activating polypeptide-II (EMAP-II) is a novel multifunctional polypeptide with proinflammatory activity. We have previously shown that the recombinant and native forms of EMAP-II can induce apoptosis in mitogen-stimulated lymphocytes, and that the release of this protein...

  • VEGF attenuates development from cardiac hypertrophy to heart failure after aortic stenosis through mitochondrial mediated apoptosis and cardiomyocyte proliferation. Xu, Xiao H.; Jing Xu; Lei Xue; Cao, Hai L.; Xiang Liu; Yi J Chen // Journal of Cardiothoracic Surgery;2011, Vol. 6 Issue 1, p54 

    Background: Aortic stenosis (AS) affects 3 percent of persons older than 65 years and leads to greater morbidity and mortality than other cardiac valve diseases. Surgery with aortic valve replacement (AVR) for severe symptomatic AS is currently the only treatment option. Unfortunately, in...

  • Enhanced growth suppression of Philadephia1 leukemia cells by targeting bcr3/abl2 and VEGF through antisense strategy. Cong, X. L.; Li, B.; Yang, R. C.; Feng, S. Z.; Chen, S. J.; Han, Z. C. // Leukemia (08876924);Sep2005, Vol. 19 Issue 9, p1517 

    An antisense strategy by targeting both bcr3/abl2 and VEGF was designed to suppress the growth of Philadephia1 leukemia cells in vitro and in vivo in mice. In vitro, although bcr3/abl2 or VEGF antisense oligodeoxyribonucleotides (AS-ODNs) alone was able to inhibit the proliferation of K562...

  • Adenoviral modification of mouse brain derived endothelial cells, bEnd3, to induce apoptosis by vascular endothelial growth factor. Mitsuuchi, Y.; Powell, D. R.; Gallo, J. M. // Oncogene;2/9/2006, Vol. 25 Issue 6, p954 

    A second generation genetically-engineered cell-based drug delivery system, referred to as apoptotic-induced drug delivery (AIDD), was developed using endothelial cells (ECs) that undergo apoptosis upon binding of vascular endothelial growth factor (VEGF) to a Flk-1:Fas fusion protein (FF). This...

  • Ninjurin1 mediates macrophage-induced programmed cell death during early ocular development. Lee, H.-J.; Ahn, B. J.; Shin, M. W.; Jeong, J.-W.; Kim, J. H.; Kim, K.-W. // Cell Death & Differentiation;Oct2009, Vol. 16 Issue 10, p1395 

    Developmental tissues go through regression, remodeling, and apoptosis. In these processes, macrophages phagocytize dead cells and induce apoptosis directly. In hyaloid vascular system (HVS), macrophages induce apoptosis of vascular endothelial cells (VECs) by cooperation between the Wnt and...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics